Soo-Jin Kim
Chief Tech/Sci/R&D Officer bij INOZYME PHARMA, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Soo-Jin Kim is currently the Chief Technical Operations Officer & Senior VP at Inozyme Pharma, Inc. Prior to this, he worked as a Principal Scientist at Bristol Myers Squibb Co., Senior Research & Head-API Development Group at Boehringer Ingelheim Pharmaceuticals, Inc., and Senior Vice President & Head-Bio Plant at Hanmi Pharmaceutical Co., Ltd.
Kim received his undergraduate degree from Cornell University and his graduate and doctorate degrees from the California Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ILSHIN SPINNING CO., LTD
1.31% | 26-04-2023 | 305 460 ( 1.31% ) | 2 M $ | 31-03-2024 |
Actieve functies van Soo-Jin Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| INOZYME PHARMA, INC. | Chief Tech/Sci/R&D Officer | 08-03-2022 |
Eerdere bekende functies van Soo-Jin Kim
| Bedrijven | Functie | Einde |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
| HANMI PHARM. CO., LTD. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Opleiding van Soo-Jin Kim
| Cornell University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| HANMI PHARM. CO., LTD. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
